Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Hainaut

Showing results (121-130 of 280) with videos related to

Pageof 28
Sort By:
Clinical Chemistry|June 25, 2005
Arrayed primer extension resequencing of mutations in the TP53 tumor suppressor gene: comparison with denaturing HPLC and direct sequencingFlorence Le Calvez, Aune Ahman, Neeme Tonisson, et al.
The American Journal of Surgical Pathology|September 10, 2002
Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomachPhilippe Taniere, Giovanna Borghi-Scoazec, Jean-Christophe Saurin, et al.
Epigenetics|August 9, 2011
Methylation patterns in sentinel genes in peripheral blood cells of heavy smokers: Influence of cruciferous vegetables in an intervention studyChiara Scoccianti, Fulvio Ricceri, Pietro Ferrari, et al.
Human Mutation|January 17, 2002
Integrating mutation data and structural analysis of the TP53 tumor-suppressor proteinAndrew C R Martin, Angelo M Facchiano, Alison L Cuff, et al.
Molecular Oncology|April 23, 2009
Mutant p53 targeting by the low molecular weight compound STIMA-1Nicole Zache, Jeremy M R Lambert, Nina Rökaeus, et al.
Plos One|November 22, 2013
Hormonal therapy and risk of breast cancer in mexican womenAmina Amadou, Alban Fabre, Gabriela Torres-Mejía, et al.
Carcinogenesis|December 1, 2007
In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249Hong Shi, Jeremy M R Lambert, Agnes Hautefeuille, et al.
Bulletin Du Cancer|January 17, 2022
[Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers]Alexandre Perrier, Pierre Hainaut, Alexandre Guenoun, et al.
Mutagenesis|September 25, 2004
TP53 mutations in squamous-cell carcinomas of the conjunctiva: evidence for UV-induced mutagenesisCharles Ateenyi-Agaba, Min Dai, Florence Le Calvez, et al.
European Journal of Human Genetics : EJHG|March 3, 2026
Tumor patterns and cancer risk in carriers of TP53 exonic germline variants that alter mRNA splicingDeborah Schönegger, Emilie Montellier, Sandrine Blanchet, et al.
Pageof 28

Showing results (121-130 of 280) with videos related to

Sort By:
Pageof 28
Clinical Chemistry|June 25, 2005
Arrayed primer extension resequencing of mutations in the TP53 tumor suppressor gene: comparison with denaturing HPLC and direct sequencingFlorence Le Calvez, Aune Ahman, Neeme Tonisson, et al.
The American Journal of Surgical Pathology|September 10, 2002
Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomachPhilippe Taniere, Giovanna Borghi-Scoazec, Jean-Christophe Saurin, et al.
Epigenetics|August 9, 2011
Methylation patterns in sentinel genes in peripheral blood cells of heavy smokers: Influence of cruciferous vegetables in an intervention studyChiara Scoccianti, Fulvio Ricceri, Pietro Ferrari, et al.
Human Mutation|January 17, 2002
Integrating mutation data and structural analysis of the TP53 tumor-suppressor proteinAndrew C R Martin, Angelo M Facchiano, Alison L Cuff, et al.
Molecular Oncology|April 23, 2009
Mutant p53 targeting by the low molecular weight compound STIMA-1Nicole Zache, Jeremy M R Lambert, Nina Rökaeus, et al.
Plos One|November 22, 2013
Hormonal therapy and risk of breast cancer in mexican womenAmina Amadou, Alban Fabre, Gabriela Torres-Mejía, et al.
Carcinogenesis|December 1, 2007
In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249Hong Shi, Jeremy M R Lambert, Agnes Hautefeuille, et al.
Bulletin Du Cancer|January 17, 2022
[Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers]Alexandre Perrier, Pierre Hainaut, Alexandre Guenoun, et al.
Mutagenesis|September 25, 2004
TP53 mutations in squamous-cell carcinomas of the conjunctiva: evidence for UV-induced mutagenesisCharles Ateenyi-Agaba, Min Dai, Florence Le Calvez, et al.
European Journal of Human Genetics : EJHG|March 3, 2026
Tumor patterns and cancer risk in carriers of TP53 exonic germline variants that alter mRNA splicingDeborah Schönegger, Emilie Montellier, Sandrine Blanchet, et al.
Pageof 28